Business Insider

Dompé receives FDA approval of Oxervate™ eye drops (cenegermin-bkbj ophthalmic solution), first-in-class recombinant human nerve growth factor with potential to completely ...

MILAN and SAN BRUNO, Calif., Aug. 22, 2018 /PRNewswire/ -- Dompé today announced that the U.S. Food and Drug Administration (FDA) has approved Oxervate TM (cenegermin-bkbj ophthalmic solution), a ...
BioWorld

Win for Oxervate eye drops from Dompe means non-surgical therapy for rare eye disease

BioWorld - Wednesday, October 9, 2024 See today's BioWorld Home » Win for Oxervate eye drops from Dompe means non-surgical therapy for rare eye disease Subscribe to BioWorld™ news services See ...
Ophthalmology Times

Refractory dry eye care: How systemic conditions change the game

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...
Medical News Today

What eye drops might a doctor prescribe for glaucoma?

Glaucoma occurs due to optic nerve damage. A common treatment is prescription eye drops. Although eye drops do not cure or reverse vision loss, they can help prevent optic nerve damage. Glaucoma ...
ABC News

Why are so many eye drops being recalled?

Experts say one reason is in-person faculty inspections slowed during COVID-19. There have been dozens of eye drops pulled off shelves in the past year due to bacterial and fungal contamination, with ...